BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soffin EM, Evans ML, Gill CH, Harries MH, Benham CD, Davies CH. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology 2002;42:127-33. [PMID: 11750922 DOI: 10.1016/s0028-3908(01)00156-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Mieda M, Tsujino N, Sakurai T. Differential roles of orexin receptors in the regulation of sleep/wakefulness. Front Endocrinol (Lausanne) 2013;4:57. [PMID: 23730297 DOI: 10.3389/fendo.2013.00057] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
2 Conrad KL, Davis AR, Silberman Y, Sheffler DJ, Shields AD, Saleh SA, Sen N, Matthies HJ, Javitch JA, Lindsley CW, Winder DG. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes. Neuropsychopharmacology 2012;37:2253-66. [PMID: 22617356 DOI: 10.1038/npp.2012.76] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
3 Okumura T, Takakusaki K. Role of orexin in central regulation of gastrointestinal functions. J Gastroenterol 2008;43:652-60. [PMID: 18807126 DOI: 10.1007/s00535-008-2218-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
4 Shirasaka T, Yonaha T, Onizuka S, Tsuneyoshi I. Effects of orexin-A on propofol anesthesia in rats. J Anesth 2011;25:65-71. [PMID: 21153424 DOI: 10.1007/s00540-010-1071-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
5 Tortorella S, Rodrigo-Angulo ML, Núñez A, Garzón M. Synaptic interactions between perifornical lateral hypothalamic area, locus coeruleus nucleus and the oral pontine reticular nucleus are implicated in the stage succession during sleep-wakefulness cycle. Front Neurosci 2013;7:216. [PMID: 24311996 DOI: 10.3389/fnins.2013.00216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Langmead CJ, Jerman JC, Brough SJ, Scott C, Porter RA, Herdon HJ. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br J Pharmacol 2004;141:340-6. [PMID: 14691055 DOI: 10.1038/sj.bjp.0705610] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 5.8] [Reference Citation Analysis]
7 Chen XW, Mu Y, Huang HP, Guo N, Zhang B, Fan SY, Xiong JX, Wang SR, Xiong W, Huang W, Liu T, Zheng LH, Zhang CX, Li LH, Yu ZP, Hu ZA, Zhou Z. Hypocretin-1 potentiates NMDA receptor-mediated somatodendritic secretion from locus ceruleus neurons. J Neurosci 2008;28:3202-8. [PMID: 18354023 DOI: 10.1523/JNEUROSCI.4426-07.2008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
8 Tsitolovsky LE. Protection from neuronal damage evoked by a motivational excitation is a driving force of intentional actions. Brain Res Brain Res Rev 2005;49:566-94. [PMID: 16269320 DOI: 10.1016/j.brainresrev.2005.02.006] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
9 Babaie F, Kourosh-Arami M, Farhadi M. Administration of Orexin-A into the Rat Thalamic Paraventricular Nucleus Enhances the Naloxone Induced Morphine Withdrawal. Drug Res (Stuttg) 2022;72:209-14. [PMID: 35385881 DOI: 10.1055/a-1744-5868] [Reference Citation Analysis]
10 Schöne C, Burdakov D. Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain. Curr Top Behav Neurosci 2017;33:51-74. [PMID: 27830577 DOI: 10.1007/7854_2016_45] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
11 Gompf HS, Aston-Jones G. Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity. Brain Res 2008;1224:43-52. [PMID: 18614159 DOI: 10.1016/j.brainres.2008.05.060] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
12 Deadwyler SA, Porrino L, Siegel JM, Hampson RE. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J Neurosci 2007;27:14239-47. [PMID: 18160631 DOI: 10.1523/JNEUROSCI.3878-07.2007] [Cited by in Crossref: 186] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
13 Carter ME, Brill J, Bonnavion P, Huguenard JR, Huerta R, de Lecea L. Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proc Natl Acad Sci U S A 2012;109:E2635-44. [PMID: 22955882 DOI: 10.1073/pnas.1202526109] [Cited by in Crossref: 151] [Cited by in F6Publishing: 140] [Article Influence: 15.1] [Reference Citation Analysis]
14 Orlowska-Feuer P, Smyk MK, Palus-Chramiec K, Dyl K, Lewandowski MH. Orexin A as a modulator of dorsal lateral geniculate neuronal activity: a comprehensive electrophysiological study on adult rats. Sci Rep 2019;9:16729. [PMID: 31723155 DOI: 10.1038/s41598-019-53012-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Holton CM, Gilmour G, Wafford KA. Orexin A induced increases in rat locus coeruleus neuronal activity are attenuated by systemic administration of OX1R and OX2R antagonists. Medicine in Drug Discovery 2020;7:100055. [DOI: 10.1016/j.medidd.2020.100055] [Reference Citation Analysis]
16 Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motoneurons. J Neurosci 2004;24:5336-45. [PMID: 15190106 DOI: 10.1523/JNEUROSCI.4812-03.2004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
17 Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP, Akaoka H, Sergeeva OA, Yanagisawa M, Ohtsu H, Franco P, Haas HL, Lin JS. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 2009;29:14423-38. [PMID: 19923277 DOI: 10.1523/JNEUROSCI.2604-09.2009] [Cited by in Crossref: 131] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
18 Kourosh-arami M, Kaeidi A, Semnanian S. Extracellular Calcium Contributes to Orexin-Induced Postsynaptic Excitation of the Rat Locus Coeruleus Neurons. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10379-0] [Reference Citation Analysis]
19 Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005;46:787-98. [PMID: 15924864 DOI: 10.1016/j.neuron.2005.04.035] [Cited by in Crossref: 579] [Cited by in F6Publishing: 545] [Article Influence: 34.1] [Reference Citation Analysis]
20 Sears RM, Fink AE, Wigestrand MB, Farb CR, de Lecea L, Ledoux JE. Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus. Proc Natl Acad Sci U S A 2013;110:20260-5. [PMID: 24277819 DOI: 10.1073/pnas.1320325110] [Cited by in Crossref: 110] [Cited by in F6Publishing: 101] [Article Influence: 12.2] [Reference Citation Analysis]
21 Sharf R, Sarhan M, Dileone RJ. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 2008;64:175-83. [PMID: 18423425 DOI: 10.1016/j.biopsych.2008.03.006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 7.5] [Reference Citation Analysis]
22 Schwartz MD, Nguyen AT, Warrier DR, Palmerston JB, Thomas AM, Morairty SR, Neylan TC, Kilduff TS. Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep. eNeuro. 2016;3:pii: ENEURO.0018-16.2016. [PMID: 27022631 DOI: 10.1523/eneuro.0018-16.2016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
23 van den Top M, Nolan MF, Lee K, Richardson PJ, Buijs RM, Davies CH, Spanswick D. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J Physiol. 2003;549:809-821. [PMID: 12702746 DOI: 10.1113/jphysiol.2002.033290] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 4.1] [Reference Citation Analysis]
24 Sanchez-Padilla J, Guzman JN, Ilijic E, Kondapalli J, Galtieri DJ, Yang B, Schieber S, Oertel W, Wokosin D, Schumacker PT, Surmeier DJ. Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase. Nat Neurosci 2014;17:832-40. [PMID: 24816140 DOI: 10.1038/nn.3717] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 10.4] [Reference Citation Analysis]
25 Schwartz MD, Kilduff TS. The Neurobiology of Sleep and Wakefulness. Psychiatr Clin North Am 2015;38:615-44. [PMID: 26600100 DOI: 10.1016/j.psc.2015.07.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
26 Takakusaki K, Takahashi K, Saitoh K, Harada H, Okumura T, Kayama Y, Koyama Y. Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J Physiol 2005;568:1003-20. [PMID: 16123113 DOI: 10.1113/jphysiol.2005.085829] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 4.4] [Reference Citation Analysis]